• Paul M Palevsky, Kathleen D Liu, Patrick D Brophy, Lakhmir S Chawla, Chirag R Parikh, Charuhas V Thakar, Ashita J Tolwani, Sushrut S Waikar, and Steven D Weisbord.
• Renal Section, VA Pittsburgh Healthcare System, Pittsburgh, PA 14240, USA. palevsky@pitt.edu
• Am. J. Kidney Dis. 2013 May 1;61(5):649-72.

AbstractIn response to the recently released 2012 KDIGO (Kidney Disease: Improving Global Outcomes) clinical practice guideline for acute kidney injury (AKI), the National Kidney Foundation organized a group of US experts in adult and pediatric AKI and critical care nephrology to review the recommendations and comment on their relevancy in the context of current US clinical practice and concerns. The first portion of the KDIGO guideline attempts to harmonize earlier consensus definitions and staging criteria for AKI. While the expert panel thought that the KDIGO definition and staging criteria are appropriate for defining the epidemiology of AKI and in the design of clinical trials, the panel concluded that there is insufficient evidence to support their widespread application to clinical care in the United States. The panel generally concurred with the remainder of the KDIGO guidelines that are focused on the prevention and pharmacologic and dialytic management of AKI, although noting the dearth of clinical trial evidence to provide strong evidence-based recommendations and the continued absence of effective therapies beyond hemodynamic optimization and avoidance of nephrotoxins for the prevention and treatment of AKI.Published by Elsevier Inc.

13 keywords...

hide…